The laboratory practices of Theranos, the embattled blood-testing startup led by entrepreneur Elizabeth Holmes, “pose immediate jeopardy to patient safety,” according to a letter from the U.S. Department of Health and Human Services on Monday.
The Theranos lab was surveyed by the Centers for Medicare and Medicaid Services for compliance with the Clinical Laboratory Improvement Amendments of 1988 on Nov. 20, 2015.
The lab was found deficient for hematology (the study of blood), analytic systems, and other practices.
Developing story…
This article originally appeared on Fortune.com
More Must-Reads From TIME
- The Man Who Thinks He Can Live Forever
- Rooftop Solar Power Has a Dark Side
- How a Government Shutdown Could Affect You
- Colleges Get Creative to Boost Mental Health
- Is It Flu, COVID-19, or RSV? Navigating At-Home Tests
- Paul Hollywood Answers All of Your Questions About The Great British Baking Show
- How Canada and India's Relationship Crumbled
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
